Application 210160
- Type
- ANDA
- Sponsor
- TORRENT PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ALOGLIPTIN; METFORMIN HYDROCHLORIDE | ALOGLIPTIN; METFORMIN HYDROCHLORIDE | TABLET;ORAL | EQ 12.5MG BASE;500MG | No | No |
| 002 | ALOGLIPTIN; METFORMIN HYDROCHLORIDE | ALOGLIPTIN; METFORMIN HYDROCHLORIDE | TABLET;ORAL | EQ 12.5MG BASE;1GM | No | No |
Source provenance: Browse the complete Orange Book source catalog.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 57277 | ORIG | 2019-01-18 |